{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:55:01Z","timestamp":1769000101096,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.lrr.2021.100286","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T12:27:07Z","timestamp":1639484827000},"page":"100286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome\/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen"],"prefix":"10.1016","volume":"17","author":[{"given":"Nikeeta","family":"Mandhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha","family":"Badar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lrr.2021.100286_bib0001","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOH.0000000000000571","article-title":"Myeloid sarcoma","volume":"27","author":"Shahin","year":"2020","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.lrr.2021.100286_bib0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.lrr.2021.100286_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.lrr.2021.100286_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"issue":"29","key":"10.1016\/j.lrr.2021.100286_bib0005","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.lrr.2021.100286_bib0006","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lrr.2021.100286_bib0007","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.lrr.2021.100286_bib0008","first-page":"47","article-title":"Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization","volume":"33","author":"Geok Chin","year":"2011","journal-title":"Malays. J. Pathol."},{"issue":"3","key":"10.1016\/j.lrr.2021.100286_bib0009","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-016-2870-0","article-title":"Evidence for a role of decitabine in the treatment of myeloid sarcoma","volume":"96","author":"Gornicec","year":"2017","journal-title":"Ann. Hematol."},{"issue":"1\u20132","key":"10.1016\/j.lrr.2021.100286_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10428199609067593","article-title":"Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia","volume":"21","author":"Byrd","year":"1996","journal-title":"Leuk. Lymphoma"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:09:13Z","timestamp":1761959353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048921000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":10,"alternative-id":["S2213048921000534"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100286","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome\/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100286"}}